The diabetes pandemic is a reality which currently affects around 462 million people worldwide, and that number is growing rapidly, estimated to reach more than 700 million by 2045. The disease already accounts for a staggering 10% of global health expenditure (USD 760 billion). And with Type 2 diabetes being propelled by modern high-calorie, processed … Continue reading Rethinking Diabetes Drug Discovery